Triangle specialty pharmaceutical company developing nanoparticle drug products through the NanoCont continuous-manufacturing platform; pipeline reformulates approved small molecules via the 505(b)(2) pathway.
At a glance
- Founded: 2015
- HQ: Durham
- Sector: Biotech
Open roles
All open Triangle rolesThe rest of this record is behind a free account.
Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately, and I read every signup.